Corporate News     06-Nov-23
Zydus receives USFDA approval for ZITUVIMET™ (Sitagliptin and Metformin hydrochloride) tablets
Zydus Lifesciences announced that the U.S. Food and Drug Administration (FDA) approved its New Drug Application (NDA) for ZITUVIMET™ (Sitagliptin and Metformin hydrochloride) tablets, 50 mg/500 mg and 50 mg/1000 mg.

ZITUVIMET™ contains active ingredients sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, and metformin hydrochloride (HCl), a biguanide, indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Previous News
  Zydus Lifesciences Ltd spurts 0.43%, up for five straight sessions
 ( Hot Pursuit - 08-Jul-24   13:01 )
  Indices trade with moderate losses; PSU bank shares decline
 ( Market Commentary - Mid-Session 23-Jul-24   14:31 )
  Zydus Lifesciences receives USFDA tentative approval for Diroximel Fumarate Delayed-Release Capsules
 ( Corporate News - 10-Jul-24   16:03 )
  Zydus Life’s Gujarat facility gets OAI status from USFDA
 ( Hot Pursuit - 17-Jun-24   08:58 )
  Zydus receives USFDA approval for Sacubitril and Valsartan Tablets
 ( Corporate News - 10-Jul-24   16:12 )
  Sensex up 203 pts, oil & gas shares advance
 ( Market Commentary - Mid-Session 24-Apr-24   14:36 )
  Zydus and Guardant Health sign co-marketing agreement to promote Guardant360® portfolio for precision oncology
 ( Corporate News - 02-Nov-23   13:03 )
  Zydus Lifesciences consolidated net profit rises 298.62% in the March 2024 quarter
 ( Results - Announcements 17-May-24   16:25 )
  Zydus Life Ahmedabad facility gets 4 USFDA observations
 ( Hot Pursuit - 28-Mar-24   11:03 )
  Zydus Lifesciences appoints director
 ( Corporate News - 17-May-24   15:47 )
  Zydus receives USFDA approval for Bisoprolol Fumarate Tablets
 ( Corporate News - 26-Jul-22   18:16 )
Other Stories
  RACL Geartech receives ratings action from CARE
  05-Oct-24   14:24
  JHS Svendgaard Retail Ventures EGM scheduled
  05-Oct-24   13:50
  Lexus Granito (India) EGM scheduled
  05-Oct-24   13:50
  Latteys Industries EGM scheduled
  05-Oct-24   13:50
  Embassy Office Parks REIT to convene board meeting
  05-Oct-24   13:50
  Board of Fusion Micro Finance appoints director
  05-Oct-24   13:17
  Board of Fusion Micro Finance approves rights issue of Rs 550 cr
  05-Oct-24   13:15
  Bharti Airtel deploys additional spectrum in Jammu-Kashmir & Leh Ladakh
  05-Oct-24   12:53
  Dr Reddys announces incorporation of new step-down subsidiary in Denmark
  05-Oct-24   11:37
  360 ONE WAM grants 21.47 lakh stock options
  05-Oct-24   11:32
Back Top